Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tamara A. Miskowski"'
Autor:
Chaozhong Cai, Alexey B. Dyatkin, Paul R. Wade, Kavash Robert W, Sui-Po Zhang, Henry J. Breslin, Craig J. Diamond, Wei He, Tamara A. Miskowski, Pamela J. Hornby
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:4869-4872
A small set of acyclic analogs 5 were prepared to explore their structure-activity relationships (SARs) relative to heterocyclic core, opioid receptor (OR) agonists 4. Compound 5l was found to have very favorable OR binding affinities at the δ and
Autor:
Pamela J. Hornby, Bruce P. Damiano, Alexey B. Dyatkin, N. H. Wallace, M. Carolyn Fisher, Stephen M. Prouty, Bruce E. Maryanoff, Edward S. Kimball, Wei He, Rosemary J. Santulli, Craig R. Schneider, Yong Gong, William A. Kinney, Craig J. Diamond, Tamara A. Miskowski
Publikováno v:
Bioorganic & Medicinal Chemistry. 13:6693-6702
A series of N-carboxy, N-alkyl, and N-carboxamido azabicyclo[2.2.2]octane carboxamides were prepared and assayed for inhibition of α4β1-VCAM-1 and α4β7-MAdCAM-1 interactions. Potency and α4β1/α4β7 selectivity were sensitive to the substituent
Publikováno v:
Journal of Molecular Graphics and Modelling. 23:409-418
A homology model of the active site region of tripeptidyl peptidase II (TPP II) was constructed based on the crystal structures of four subtilisin-like templates. The resulting model was subsequently validated by judging expectations of the model ver
Autor:
Jeffrey M. Palmer, Mark Schulz, Alexey B. Dyatkin, Joseph G. Lisko, Pamela J. Hornby, Janet L. Ralbovsky, Kristen M. Chevalier, Wei He, John R. Mabus, Tamara A. Miskowski, Steven J. Coats
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(10)
A series of guanidine triazinediones were identified as potent PK1 receptor antagonists. A compound in this series inhibited the PK1 invoked prosecretory response in rat ileum tissue.
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists
Autor:
Yong Gong, Barbay Jk, Dennis J. Hlasta, Stephen M. Prouty, Scott A. Ballentine, Patricia Andrade-Gordon, Alexey B. Dyatkin, William Hageman, John A. Masucci, Rosemary J. Santulli, M. C. Fisher, Pamela J. Hornby, Wei He, N. H. Wallace, Bruce P. Damiano, Craig R. Schneider, Tamara A. Miskowski, Edward S. Kimball, Bruce E. Maryanoff
Publikováno v:
Journal of medicinal chemistry. 49(11)
A novel series of pyridazinone-functionalized phenylalanine analogues was prepared and evaluated for inhibition of cellular adhesion mediated by alpha4beta1/VCAM-1 and alpha4beta7/MAdCAM-1 interactions. Concise syntheses were developed and applied fo
Autor:
Tamara A. Miskowski, Raymond W. Colburn, Jian Li, Jeffrey M. Palmer, Wei He, Dennis J. Stone, N. H. Wallace, Rebecca P. Martinez, Craig R. Schneider, Sui-Po Zhang, Henry J. Breslin, Bryan M. Rafferty, Edward S. Kimball, Santosh V. Coutinho
Publikováno v:
Journal of medicinal chemistry. 47(21)
A small series of novel, imidazoles 4 have been prepared that exhibit very good binding affinities for the delta and mu opioid receptors (ORs), as well as demonstrate potent agonist functional activity at the delta OR. Representative imidazole 4a (K(
Autor:
Peter Walter Maria Roevens, Hans De Winter, Kavash Robert W, Michael Joseph Kukla, Maria V. F. Somers, Henry J. Breslin, Tamara A. Miskowski
Publikováno v:
ChemInform. 35
We have systematically explored the structure–activity relationship (SAR) for a series of compounds 2 as inhibitors of tripeptidyl-peptidase II (TPP II), a serine protease responsible for the degradation of cholecystokinin-8 (CCK-8). This SAR evalu
Autor:
Maria V. F. Somers, Tamara A. Miskowski, Michael Joseph Kukla, Peter Walter Maria Roevens, Hans De Winter, Kavash Robert W, Henry J. Breslin
Publikováno v:
Bioorganicmedicinal chemistry letters. 13(24)
We have systematically explored the structure–activity relationship (SAR) for a series of compounds 2 as inhibitors of tripeptidyl-peptidase II (TPP II), a serine protease responsible for the degradation of cholecystokinin-8 (CCK-8). This SAR evalu
Autor:
Hans De Winter, Tamara A. Miskowski, Daniëlle C G Peeters, Diane A. Gauthier, Henry J. Breslin, Michael Joseph Kukla, William H Leister, Maria V. F. Somers, Peter Walter Maria Roevens
Publikováno v:
Journal of medicinal chemistry. 45(24)
Butabindide, 1, was previously reported as a potent inhibitor (IC50 = 7 nM) of the serine protease enzyme tripeptidyl peptidase II (TPPII), an endogenous protease that degrades cholecystokinin-8 (CCK-8). We found that 1 has some inherent chemical ins